GE Debuts PET/MR
GE Healthcare will debut at RSNA 2014 their SIGNA PET/MR system.
GE Healthcare will showcase at RSNA 2014 the SIGNA PET/MR, which GE calls the world’s first time-of-flight capable, integrated, simultaneous PET/MR system.
The SIGNA PET/MR is powered by simultaneous image acquisition from GE’s latest 3.0 Tesla magnetic resonance (MR) technology, and innovative positron emission tomography (PET) technology and offers clinicians improved scan efficiency that may lead to more effective treatment paths, GE said.
The SIGNA PET/MR features GE’s MR-compatible silicon photomultiplier detector (SiPM) technology, which is categorized by its enhanced sensitivity, GE said. It also features fast coincidence timing resolution, enabling TOF reconstruction, GE said. TOF helps to improve PET image quality with the potential for higher structural detail and signal-to-noise ratio, GE said. The SIGNA PET/MR should be fully upgradable form a Discovery MR750w 3.0T.
The SIGNA PET/MR is 510(k) pending at the FDA.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
FDA Issues Expanded Pediatric Approval of MRI Contrast Agent for Lung Ventilation Assessment
June 2nd 2025Previously approved for MRI lung ventilation evaluation in adults and children 12 and older, the hyperpolarized contrast agent Xenoview can now be utilized for pediatric patients six years and older.
